WuXi AppTec (OTCMKTS:WUXAY) Shares Down 4.9% – Here’s What Happened

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY)’s stock price was down 4.9% on Tuesday . The stock traded as low as $14.6816 and last traded at $14.7350. Approximately 1,463 shares changed hands during mid-day trading, a decline of 14% from the average daily volume of 1,695 shares. The stock had previously closed at $15.50.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of WuXi AppTec to a “hold” rating in a research report on Monday, April 13th. One research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy”.

WuXi AppTec Price Performance

The firm’s 50-day moving average is $16.29 and its 200-day moving average is $14.88.

WuXi AppTec (OTCMKTS:WUXAY) last posted its quarterly earnings data on Monday, April 27th. The company reported $0.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.18 by $0.05. The firm had revenue of $1.82 billion for the quarter, compared to analysts’ expectations of $1.59 billion.

WuXi AppTec Company Profile

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.